The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Man fleeing cops in western Michigan dies after unmarked cruiser hits him
Hometown hero soars in Shanghai
Nation's big progress in IP to help advance tech ties
Xi Extends Congratulations on DPRK's 75th Founding Anniversary
Inside luxury brands' STAGGERING price hikes
Elementary school students participated in after
Dickov confident the future's blue
Xi's Reply Letter : A Testament to Five Generations of Friendship
Barcelona to get floating desalination plant to help fight drought in northeastern Spain
China's basketball star Yi Jianlian announces retirement
Fire in truck carrying lithium ion batteries leads to 3
Chinese auto industry hits milestones in 2023